Tech Company M&A Transactions

aFraxis Acquisition

aFraxis, operating out of La Jolla, was bought by Genentech. The transaction price was $187.5 million.

Transaction Overview

Company Name
Acquired By
Announced On
1/31/2013
Transaction Type
M&A
Amount
$187,500,000
M&A Terms
Under the terms of the agreement, Genentech willhave exclusive, worldwide rights to develop and commercialize Afraxis'proprietary compounds. Afraxis is eligible to receive upfront, research,development and commercialization milestone payments, together totaling up to $187.5 million.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
11099 N Torrey Pines Rd. 290
La Jolla, CA 92037
USA
Email Address
Overview
Afraxis is discovering and developing drugs to treat diseases of the central nervous system, including schizophrenia, Alzheimer's disease, Fragile X syndrome and autism spectrum disorders. Recent scientific discoveries have linked these disorders to underlying defects in the development and function of specialized structures of the neural synapse, called dendritic spines.
Profile
aFraxis LinkedIn Company Profile
Social Media
aFraxis Company Twitter Account
Company News
aFraxis News
Facebook
aFraxis on Facebook
YouTube
aFraxis on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jay Lichter
  Jay Lichter LinkedIn Profile  Jay Lichter Twitter Account  Jay Lichter News  Jay Lichter on Facebook
Chief Scientific Officer
David Campbell
  David Campbell LinkedIn Profile  David Campbell Twitter Account  David Campbell News  David Campbell on Facebook
VP - Bus. Development
Carmine Stengone
  Carmine Stengone LinkedIn Profile  Carmine Stengone Twitter Account  Carmine Stengone News  Carmine Stengone on Facebook
VP - R & D
Christopher Rex
  Christopher Rex LinkedIn Profile  Christopher Rex Twitter Account  Christopher Rex News  Christopher Rex on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/31/2013: nFluence Media venture capital transaction
Next: 1/31/2013: 42Floors venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary